"Mount Sinai Invests $200M into New Precision Medicine Data Science Program"
Icahn School of Medicine at Mount Sinai is investing $200 million into a new program to fast-track drug discoveries through the integration of large-scale data analysis and genomic technologies. The school also said it has recruited Adam Margolin, PhD, former director of computation biology at Oregon Health & Science University, to lead the initiative. Dr. Margolin, who will replace Eric Schadt at Mount Sinai, is a leader in the development of machine-learning algorithms to analyze large-scale datasets that predict which patients will respond to treatments. He has also developed software systems to enable collaborative analysis within national and international projects in cancer, genomics, cancer immunotherapy, stem cell research, and pediatric diseases. "We will bring together the top data scientists, genomic technology innovators, and disease experts who will work side by side every day to understand the molecular causes of complex diseases, rapidly test new therapies derived from these insights, and bring these therapies to patients faster than ever before,” said Dr. Margolin.
— Adam Margolin, PhD, Professor, Chair, Department of Genetics and Genomic Sciences, Senior Associate Dean, Precision Medicine, Director, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.